Today: 21 June 2026

UnitedHealth stock in focus after rural hospital payment pilot — and a Senate Medicare report

UnitedHealth stock in focus after rural hospital payment pilot — and a Senate Medicare report

UnitedHealth shares rose 0.3% to $334.96 in after-hours trading after its UnitedHealthcare unit launched a pilot to speed Medicare Advantage payments to rural hospitals. The move comes as a Senate committee report accuses UnitedHealth of inflating reimbursements through aggressive coding, which the company disputes. Investors await UnitedHealth’s 2026 outlook on Jan. 27.
15 January 2026
Morgan Stanley stock slips before earnings as Wall Street digests big-bank signals

Morgan Stanley stock slips before earnings as Wall Street digests big-bank signals

Morgan Stanley shares fell 1.1% to $180.78 Wednesday, lagging peers ahead of its quarterly earnings due before Thursday’s open. Investors are focused on trading and wealth management results after a sector rally and mixed bank earnings. After-hours trading showed little movement. U.S. bank stocks slipped as policy uncertainty and uneven results weighed on sentiment.
Bloom Energy stock drops late as traders cool on data-center power bets

Bloom Energy stock drops late as traders cool on data-center power bets

Bloom Energy shares dropped 4.5% to $133.46 in after-hours trading Wednesday, reversing gains from an early January rally. The decline follows investor concerns over how quickly rising data-center power demand, driven by AI, will convert to earnings. A recent $2.65 billion order from American Electric Power had fueled last week’s surge. Broader markets also fell, with the Nasdaq down after mixed bank results.
Capital One stock steadies after hours as investors price Trump’s credit-card cap threat, $425 mln settlement

Capital One stock steadies after hours as investors price Trump’s credit-card cap threat, $425 mln settlement

Capital One shares rose 1.3% to $234.42 in after-hours trading Wednesday, recovering some ground after recent losses. A federal judge gave preliminary approval to a revised $425 million settlement for depositors. Investors are watching a proposed 10% cap on credit-card interest rates, which could hit bank profits. Capital One reports fourth-quarter earnings Jan. 22.
15 January 2026
NASA rushes SpaceX Crew-11 home after astronaut falls ill in orbit

NASA rushes SpaceX Crew-11 home after astronaut falls ill in orbit

SpaceX’s Crew Dragon undocked from the International Space Station Wednesday after a crew member developed a serious medical condition, NASA said. The capsule, carrying four astronauts, is targeting splashdown off California early Thursday. NASA reported the affected astronaut is stable but gave no details. This marks the first time a medical issue has forced an early return from the station.
Accenture stock jumps after hours as Infosys outlook lifts IT services mood

Accenture stock jumps after hours as Infosys outlook lifts IT services mood

Accenture shares rose 4.3% to $288.54 in after-hours trading Wednesday, outpacing a broader market decline. Infosys raised its full-year revenue growth forecast to 3–3.5%, citing resilient tech spending. Trading volume in Accenture topped 6 million shares. Investors are watching Accenture’s Jan. 28 shareholder meeting and March earnings update.
Why High Roller Technologies stock (ROLR) jumped more than 400% after a Crypto.com prediction markets LOI

Why High Roller Technologies stock (ROLR) jumped more than 400% after a Crypto.com prediction markets LOI

High Roller Technologies shares surged about 437% to $18.89 in after-hours trading Wednesday after announcing a letter of intent for a prediction-markets partnership with Crypto.com. The deal remains non-binding, with final agreements pending and a Q1 2026 product launch targeted. Trading volume topped 80 million shares. Investors await definitive contracts and further details.
Eli Lilly stock dips after hours as FDA seeks label change for Zepbound, traders eye obesity pill push

Eli Lilly stock dips after hours as FDA seeks label change for Zepbound, traders eye obesity pill push

Eli Lilly shares fell about 0.3% in after-hours trading Wednesday after the FDA asked drugmakers to remove suicide-risk warnings from GLP-1 weight-loss drugs. The agency found no link between the drugs and increased suicide risk. Investors are watching Lilly’s plans for its oral obesity drug, orforglipron, which could launch soon at a $150 monthly price.
Mastercard stock steadies after Washington jolt as Jan. 29 earnings loom

Mastercard stock steadies after Washington jolt as Jan. 29 earnings loom

Mastercard shares closed at $547.99 on Wednesday, up 0.6%, then slipped to $546.82 in after-hours trading amid renewed U.S. political pressure on credit-card fees. Senators reintroduced the Credit Card Competition Act, targeting Visa and Mastercard’s control over transaction routing. Analysts warn valuations could drop 10%–20%. Mastercard reports fourth-quarter earnings Jan. 29.
Robinhood stock slips after hours as Senate crypto bill and bitcoin rebound reshape the setup

Robinhood stock slips after hours as Senate crypto bill and bitcoin rebound reshape the setup

Robinhood Markets shares fell 0.5% to $119.67 in after-hours trading Wednesday, lagging other crypto stocks despite bitcoin gains. U.S. senators introduced a draft bill late Monday to clarify crypto regulation, with a Senate Banking Committee review set for Thursday. Industry groups criticized parts of the bill on stablecoin rewards. Investors await Robinhood’s Q4 and 2025 earnings on Feb. 10.
Johnson & Johnson stock rises after Tecvayli trial win as JNJ eyes earnings

Johnson & Johnson stock rises after Tecvayli trial win as JNJ eyes earnings

Johnson & Johnson shares rose 2.3% to $218.55 in after-hours trading Wednesday after reporting its Tecvayli drug cut the risk of disease progression or death by 71% in a late-stage multiple myeloma trial. An independent committee recommended unblinding the study. Full results will be presented at an upcoming medical meeting. Investors await the company’s quarterly results next week.

Stock Market Today

  • STMicroelectronics Stock Seen as 46.3% Overvalued Amid Rally
    June 21, 2026, 6:46 AM EDT. STMicroelectronics (ENXTPA:STMPA) surged 22.89% in 30 days, lifting its 1-year return to 176.27%. However, the stock trades at €67.92, about 46.3% above its estimated fair value of €46.41, suggesting overvaluation. The rally reflects optimism around industrial automation, microcontroller sales, and AI-related growth, including partnerships with NVIDIA in data centers. Despite strong momentum, risks persist such as increased competition, pricing pressure in China, and execution challenges from restructuring. Analysts caution that the premium price factors in ambitious profit growth and sector shifts, urging investors to consider a broader range of semiconductor names amid mixed outlooks.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 21.06.2026

21 June 2026
LIVEMarkets rolling coverageStarted: June 21, 2026, 4:00 AM EDTUpdated: June 21, 2026, 6:46 AM EDT STMicroelectronics Stock Seen as 46.3% Overvalued Amid Rally June 21, 2026, 6:46 AM EDT. STMicroelectronics (ENXTPA:STMPA) surged 22.89% in 30 days, lifting its 1-year return to 176.27%. However, the stock trades at €67.92, about 46.3% above its estimated fair value of €46.41, suggesting overvaluation. The rally reflects optimism around industrial automation, microcontroller sales, and AI-related growth, including partnerships with NVIDIA in data centers. Despite strong momentum, risks persist such as increased competition, pricing pressure in China, and execution challenges from restructuring. Analysts caution that the
Go toTop